Banner Good Samaritan Medical Center is building a radiopharmaceutical production facility that includes a new $1.8 million cyclotron to expand its clinical and research imaging capabilities in cancer, heart disease and neurology.
The new Banner Good Samaritan Molecular Imaging Laboratory will support all of Banner’s Arizona-based hospitals, other in-patient facilities in the state and outpatient referrals from Arizona, Nevada, New Mexico, Colorado and elsewhere, according to the Phoenix-based healthcare provider.
The researchers at the Banner Alzheimer’s Institute use PET scans to measure brain activity in people with a genetic predisposition to Alzheimer’s disease. The Institute recently started to incorporate two new PET tracers that measure amyloid plaques in the brain, a hallmark of Alzheimer’s disease, into multiple research projects.
“The new cyclotron and Molecular Imaging Laboratory will play a critical role in helping Banner fulfill its patient care and research missions,” according to Eric M. Reiman, MD, executive director of the Banner Alzheimer’s Institute.